Dr. Palwasha Anwari, Health Economics Consultant at WHO-EMRO, holds a DrPH from the London School of Hygiene and Tropical Medicine. Her work focuses on benefit-risk assessment, cost-utility analysis, and vaccine effectiveness. She supports EMRO Member States in generating economic evidence for immunization policy, including cost estimates for National Immunization Strategies, budgeting, and expenditure tracking.
Click the links below to navigate to our IHEA 2025 presentations or our general resource library where you can sort all our resources based on presenter, organizational affiliation, topic, and more.